Markus Klein,Christos Tsaklakidis,Hans Guehring,Birgitta Leuthner
申请号：
US15041712
公开号：
US09839665B2
申请日:
2016.02.11
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention relates to compounds of the formula (I) and in particular medicaments comprising at least one compound of the formula (I) for use in the treatment and/or prophylaxis of physiological and/or pathophysiological states in the triggering of which cathepsin D is involved, in particular for use in the treatment and/or prophylaxis of arthrosis, traumatic cartilage injuries, arthritis, pain, allodynia or hyperalgesia.
